Arbutus Biopharma Corp
Biotechnology
Healthcare
ABUS
191 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.50
52 week high
4.90
high
4.56
52 week low
0.00
low
4.42
growth
10.95 %
previous Close
4.43
P/E ratio
market cap
632 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
1390.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top